Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Chang

Showing results (1011-1020 of 1,110) with videos related to

Pageof 111
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2012
Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trialMohammed Ahmed Saad Almansob, Bo Xu, Li Zhou, et al.
Virology Journal|May 19, 2025
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot studyLi-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Trials|August 26, 2011
Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trialHuang-Chi Chen, Wen-Chi Chen, Kai-Huang Lin, et al.
Chang Gung Medical Journal|November 1, 2011
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanomaPo-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, et al.
European Journal of Haematology|April 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myelomaZi-Long Wang, Yang Liu, Ya-Lan Zhou, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Pageof 111

Showing results (1011-1020 of 1,110) with videos related to

Sort By:
Pageof 111
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2012
Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trialMohammed Ahmed Saad Almansob, Bo Xu, Li Zhou, et al.
Virology Journal|May 19, 2025
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot studyLi-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Trials|August 26, 2011
Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trialHuang-Chi Chen, Wen-Chi Chen, Kai-Huang Lin, et al.
Chang Gung Medical Journal|November 1, 2011
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanomaPo-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, et al.
European Journal of Haematology|April 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myelomaZi-Long Wang, Yang Liu, Ya-Lan Zhou, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Pageof 111